Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Innovations in Nipple-areolar Complex Reconstruction: Evaluation of a New Prosthesis.
Riccio M, Aquinati A, Fordellone M, Carboni N, Marchesini A, De Francesco F. Riccio M, et al. Among authors: fordellone m. Plast Reconstr Surg Glob Open. 2025 Jan 10;13(1):e6410. doi: 10.1097/GOX.0000000000006410. eCollection 2025 Jan. Plast Reconstr Surg Glob Open. 2025. PMID: 39802274 Free PMC article.
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.
Mallardo D, Fordellone M, Ottaviano M, Marano G, Vitale MG, Mallardo M, Capasso M, De Cristofaro T, Capone M, Meinardi T, Paone M, Sabatelli P, De Filippi R, Cesano A, Cavalcanti E, Caracò C, Warren S, Budillon A, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: fordellone m. Int J Mol Sci. 2024 Nov 19;25(22):12439. doi: 10.3390/ijms252212439. Int J Mol Sci. 2024. PMID: 39596506 Free PMC article.
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.
Mallardo D, Fordellone M, White A, Vowinckel J, Bailey M, Sparano F, Sorrentino A, Mallardo M, Facchini BA, De Filippi R, Ferrara G, Vanella V, Beeler K, Chiodini P, Cesano A, Warren S, Ascierto PA. Mallardo D, et al. Among authors: fordellone m. Int J Mol Sci. 2024 Aug 28;25(17):9345. doi: 10.3390/ijms25179345. Int J Mol Sci. 2024. PMID: 39273294 Free PMC article.
A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19.
Trimarco V, Izzo R, Jankauskas SS, Fordellone M, Signoriello G, Manzi MV, Lembo M, Gallo P, Esposito G, Piccinocchi R, Rozza F, Morisco C, Mone P, Piccinocchi G, Varzideh F, Trimarco B, Santulli G. Trimarco V, et al. Among authors: fordellone m. J Clin Invest. 2024 Sep 12;134(21):e183777. doi: 10.1172/JCI183777. J Clin Invest. 2024. PMID: 39264723 Free PMC article.
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.
Santagata S, Trotta AM, D'Alterio C, Napolitano M, Rea G, Di Napoli M, Portella L, Ieranò C, Guardascione G, Coppola E, Caux C, Dubois B, Boyle HJ, Carles J, Rossetti S, Azzaro R, Feroce F, Perdonà S, Fordellone M, Bello AM, Califano D, Chiodini P, Pignata S, Scala S. Santagata S, et al. Among authors: fordellone m. Clin Cancer Res. 2024 Oct 15;30(20):4755-4767. doi: 10.1158/1078-0432.CCR-24-0729. Clin Cancer Res. 2024. PMID: 39167621 Free PMC article.
Benefits of Taurisolo in Diabetic Patients with Peripheral Artery Disease.
Amato B, Novellino E, Morlando D, Vanoli C, Vanoli E, Ferrara F, Difruscolo R, Goffredo VM, Compagna R, Tenore GC, Stornaiuolo M, Fordellone M, Caradonna E. Amato B, et al. Among authors: fordellone m. J Cardiovasc Dev Dis. 2024 Jun 4;11(6):174. doi: 10.3390/jcdd11060174. J Cardiovasc Dev Dis. 2024. PMID: 38921674 Free PMC article.
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Mallardo D, Sparano F, Vitale MG, Trojaniello C, Fordellone M, Cioli E, Esposito A, Festino L, Mallardo M, Vanella V, Facchini BA, De Filippi R, Meinardi P, Ottaviano M, Caracò C, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: fordellone m. Cancer Immunol Immunother. 2024 Jun 8;73(8):160. doi: 10.1007/s00262-024-03728-z. Cancer Immunol Immunother. 2024. PMID: 38850335 Free PMC article.
19 results